Cargando…
Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018
IMPORTANCE: Improving access to naloxone is a critical component of the nation’s strategy to curb fatal overdoses in the opioid crisis. Standing or protocol orders, prescriptive authority laws, and immunity provisions have been passed by states to expand access, but less attention has been given to...
Autores principales: | Peet, Evan D., Powell, David, Pacula, Rosalie Liccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391964/ https://www.ncbi.nlm.nih.gov/pubmed/36200636 http://dx.doi.org/10.1001/jamahealthforum.2022.2663 |
Ejemplares similares
-
Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Buprenorphine Medications for Opioid Use Disorder Treatment by Type of Payer, 2015 to 2020
por: Strahan, Andrea E., et al.
Publicado: (2023) -
Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018
por: Yeung, Kai, et al.
Publicado: (2021) -
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
por: Rome, Benjamin N., et al.
Publicado: (2021) -
Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018
por: Lin, Shuo-yu, et al.
Publicado: (2021) -
Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
por: Myran, Daniel T., et al.
Publicado: (2023)